Hyperlipidemia
Conditions
Interventions
Experimental group:Chlamydomonas reinhardtii recombinant protein
Control subjects:Placebo-controlled study
Sponsors
Hefei First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 65 years old, gender is not limited. 2.Under normal diet, the blood lipid level after 12-14 hours of fasting, serum total cholesterol >=5.18mmol/L, or serum triglycerides >=1.70mmol/L. 3.Understand in detail the nature, significance, possible benefits, inconvenience and potential risks of the test, understand the study procedures and sign the informed consent form voluntarily before the test.
Exclusion criteria
Exclusion criteria: 1.Pregnant or lactating women. 2.Allergic or hypersensitive to the samples. 3.Patients with serious diseases such as heart, liver, kidney and hematopoietic system, mental illness. 4.Those who have taken lipid-lowering drugs in the last two weeks, etc., which may affect the judgment of the results. 5.Those who have undergone major surgery or have a history of severe trauma in the last month. 6.Those with coagulation disorders, active bleeding or high risk of bleeding. 7.Those who have consumed large amounts of alcohol over a long period of time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipids; | — |
Secondary
| Measure | Time frame |
|---|---|
| Coagulation; | — |
Countries
China
Contacts
Public ContactWang Shu
Hefei First People's Hospital
Outcome results
None listed